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The complex containing actin-related proteins Arp2 and Arp3 is
required for the motility and integrity of yeast actin patches
Dirk Winter*, Alexandre V. Podtelejnikov†, Matthias Mann† and Rong Li*
Background: Structural modeling and biochemical experiments in vitro have
implicated a multi-protein complex containing two actin-related proteins, Arp2
and Arp3, as a potential actin-filament nucleation factor. This ‘Arp2/3 complex’
has been identified in Acanthamoeba and human cells and has been shown to
localize to regions involved in actin-based motility, such as the leading edge of
moving cells and the ‘tail’ of actin that forms behind the intracellular pathogen
Listeria. The function of this complex in vivo has not been characterized,
however, and the sequences of the non-actin-related subunits remain to be
determined. 
Results: An Arp3 homologue from the budding yeast Saccharomyces
cerevisiae was found to localize to cortical actin patches, highly motile
structures that concentrate at sites of polarized growth during the yeast cell
cycle. A conditional arp3 mutant allele inhibited cortical actin motility at the
restrictive temperature and eventually disrupted actin patches. Most Arp3
protein is found in a multi-protein complex; we purified this complex and
determined the sequences of each of the protein subunits using a high-
accuracy mass peptide-mapping technique. The proteins found in the complex
are similar to those in the Acanthamoeba and human Arp2/3 complexes except
that the yeast complex lacks a 40 kDa subunit, which is therefore not required
for the structural integrity of the complex.
Conclusions: The Arp2/3 protein complex is conserved from yeast to man, and
in yeast the complex is required in vivo for the motility and integrity of cortical
actin patches. We hypothesize that these patches may move by a Listeria-like
mechanism driven by actin polymerization.
Background
One of the major mechanisms that govern actin
polymerization is the control of actin nucleation sites. The
formation of actin trimers, the smallest nuclei for polymer-
ization, is the rate-limiting step during spontaneous fila-
ment assembly [1,2]. Thus, cellular activities that either
bypass or stimulate trimer formation should have a large
influence on actin polymerization. Recently, a multi-
subunit protein complex that contains two actin-related
proteins, Arp2 and Arp3, has emerged as a strong candidate
for carrying out de novo nucleation of actin filaments [3–5].
The Arps are proteins that exhibit 30–60% sequence
similarity to actin, and they may nucleate actin polymeriza-
tion by interacting with actin through contacts similar to
those between actin subunits. Kelleher et al. [4] postulated
that an Arp2–Arp3 heterodimer in the complex may be
able to interact with the ‘pointed’ (less dynamic) end of an
actin subunit, but not the ‘barbed’ (more dynamic) end,
and thus may nucleate actin filament growth toward the
barbed end. The first biochemical evidence supporting a
role for the Arp2/3 complex in actin nucleation comes from
a recent study [5] which shows that the complex as purified
from human platelets is able to stimulate actin polymeriza-
tion at the surface of the pathogenic bacterium Listeria
monocytogenes. However, the Arp2/3 complex localizes
throughout the actin tail of motile Listeria, not just in the
region proximal to the bacteria where actin polymerization
occurs [5]. Another recent study [6] has demonstrated that
purified Acanthamoeba Arp2/3 complex binds to the side of
actin filaments but does not nucleate actin polymerization
in solution; the role of this complex in actin nucleation is
therefore currently controversial. Furthermore, it has not
yet been possible to deplete the Arp2/3 complex from in
vitro assay systems that support Listeria motility, nor to
disrupt the Arp2/3 complex in vivo in human or
Acanthamoeba cells, leaving the physiological function of
the complex in these organisms as yet undetermined.
Yeast genetics has been a powerful tool for studying the
function of actin-associated proteins in vivo [7], but the
yeast actin cytoskeleton has traditionally been viewed as
less dynamic than that of other eukaryotic cells, and it has
therefore not been used to study motility driven by actin
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polymerization. Two classes of structures containing actin
filaments are observed in yeast cells: actin cables that per-
meate the cytoplasm, and patch-like cortical structures
(which will be referred to here as actin patches) that con-
centrate at the sites of cell surface growth. Light and elec-
tron microscopic analyses showed that cortical actin
patches contain actin filaments [8,9] organized around a
membrane core which often appears to be an invagination
of the plasma membrane [10]. Genetic studies have
further suggested a role for cortical actin patches in mem-
brane-based processes, such as exocytosis and endocytosis
(for review, see [11]). Recent studies using green fluores-
cent protein (GFP) revealed that actin patches move
rapidly along the cortex of yeast cells [12,13]; this motility
is ATP-dependent, but it is probably not driven by actin-
based motors because it is unaffected by mutations in any
of the yeast class I or class V myosins [13]. 
Here, we show that the motility of cortical actin patches is
inhibited by a mutation affecting the yeast Arp3 protein
which is itself localized to actin patches. Most Arp3 from a
soluble cell extract is associated with a high molecular
weight protein complex. We have purified this complex,
determined the sequences of all of the subunits, and
shown that it is homologous to the Acanthamoeba Arp2/3
complex. Our results provide the first in vivo evidence
that the Arp2/3 complex is required for actin-based
motility, a function which may be conserved throughout
eukaryotic cells. 
Results
The Arp3 protein localizes to cortical actin patches in yeast
The yeast genome sequencing project identified a
Saccharomyces cerevisiae homologue of Arp3 [14]. Work by
Huang et al. [14] and our lab (this study) found that the
ARP3 gene is essential for cell viability. To gain insight
into its cellular function, we determined the localization of
Arp3 protein in a yeast strain bearing Myc-epitope-tagged
Arp3 as its sole copy of Arp3. This strain grows at a similar
rate to the wild-type (data not shown), suggesting that the
epitope tag is not detrimental to Arp3 function.
Immunofluorescent anti-Myc staining revealed that Arp3 is
present in patch-like structures. This staining was not seen
in an identical strain containing untagged Arp3 (data not
shown), indicating that the staining is specific. Double
staining with anti-actin and anti-Myc antibodies showed
that most of the Arp3-containing patches co-localize with
actin patches, but not with actin cables (Figure 1). This
result suggests that Arp3 may be involved in actin function.
Generation of conditional arp3 mutants
To study the cellular function of the yeast Arp3, we used a
mutagenic PCR strategy to generate conditional alleles of
ARP3 (see Materials and methods). Screening at 14°C and
37°C for cold and temperature sensitivity, respectively,
was carried out on 647 colonies bearing mutagenized
ARP3 plasmid as their sole copy of ARP3: eight recessive
temperature-sensitive and no cold-sensitive ARP3
mutants were isolated. All conditional arp3 mutants exhib-
ited a range of aberrant morphologies at the restrictive
temperature and did not have a uniform terminal pheno-
type (data not shown), indicating that Arp3 function is
important for cell morphogenesis, probably at more than
one stage of the cell cycle. We then focused our analysis
on arp3-2, an mutant that grew relatively well at room
temperature (23°C) but rapidly underwent growth defects
at 37°C.
As shown in Figure 2a, arp3-2 cells grew well at the
permissive temperature but their growth rate was slowed
after 1 hour at 37°C. The plating efficiency of these cells
was used to assess their viability. Dilutions of arp3-2 and
wild-type cultures were plated on YPD medium after
varying periods of time at the restrictive temperature, and
cells were allowed to grow into colonies at room tempera-
ture. A 39% reduction in plating efficiency was detected
after 1 hour at the restrictive temperature for arp3-2 cells,
520 Current Biology, Vol 7 No 7
Figure 1
Arp3 protein localizes to actin patches. RLY187 (Myc-tagged-Arp3-
expressing) yeast cells were double-stained with a mixture of goat anti-
actin and mouse anti-Myc primary antibodies, and rhodamine-
conjugated anti-goat and fluorescein-conjugated anti-mouse secondary
antibodies. The actin staining in three individual fields is shown in
(a,c,e) and the Arp3 staining in the same fields is shown in (b,d,f). The
bar represents 10 mm.
but no decrease in viability occurred for the wild-type
cells (Figure 2b) After 4 hours at the restrictive tempera-
ture, more than 90% of arp3-2 cells were unable to form
colonies. These results indicate that Arp3 function is
required for maintenance of viability during cell growth,
and that Arp3 inactivation in the mutant strain occurs
within 1 hour at the restrictive temperature.
Arp3 function is required for actin-patch motility
We then analyzed the effects of the arp3-2 mutation on
cortical actin dynamics in vivo by generating wild-type and
arp3-2 strains that expressed GFP-tagged Sac6 protein.
Sac6, a yeast fimbrin homologue, is an actin-bundling
protein that localizes to cortical actin patches [15,16].
GFP–Sac6 protein is functional, and has previously been
used for studying actin-patch movement in vivo [12]. 
Wild-type and arp3-2 strains transformed with the
GFP–Sac6 expressing plasmids were grown to log phase at
room temperature. Small quantities of cells were trans-
ferred onto glass slides and incubated at 37°C for varying
amounts of time. At 10 minute intervals, slides were
removed from the restrictive temperature, and the cells
were observed for 30 second periods using a fluorescence
microscope (for details, see Materials and methods). At the
permissive temperature, patch motility and morphology in
arp3-2 cells were indistinguishable from those of wild-type
cells. After a shift to the restrictive temperature for
30 minutes, however, a dramatic reduction in the
percentage of moving patches in arp3-2 cells became
apparent. Figure 3a shows that the distribution of actin
patches in temperature-shifted wild-type cells changed
completely during a 30 second timespan, whereas the
patch distribution of arp3-2 cells remained constant. Time-
lapse microscopy indicated that the change in actin-patch
distribution in wild-type cells was due to patch movement
(data not shown). 
The rate of actin-patch movement was difficult to measure
because the patches constantly moved in and out of the
plane of focus. Therefore, to quantify the effects of the
temperature shift on patch movement, we simply deter-
mined the percentage of the patches that were moving
during the time of observation. Moving patches were
defined as those that moved at least 1 mm within the plane
of focus or moved out of focus during a 30 second period.
In wild-type cells, the temperature shift had a transient
effect on the fraction of moving patches (from ∼90% at
0 minutes to ∼50% at 30 minutes), but patch movement
recovered to ∼70% after 40 minutes (Figure 3b). The per-
centage of moving patches in arp3-2 cells, however,
dropped rapidly and significantly (from ∼90% at 0 minutes
to ~10% at 30 minutes) after the shift to 37°C and did not
recover at later time points. The data shown in Figure 3b
are the average of two representative experiments. Slightly
slower or faster effects were observed in the different
experiments, causing the large error bars at the 20 minute
time point, but the qualitative difference  between mutant
and wild-type patch movement was reproducible.
Because the plating efficiency of arp3-2 cells decreased at
the restrictive temperature (Figure 2b), we wanted to
address whether the loss of patch motility was simply due
to cell lethality or a metabolic effect, such as ATP deple-
tion. As a cell can become unable to form a colony before it
is physically dead, we used the vital dye methylene blue to
assess the viability of individual cells. Cells were grown in
a sealed environment without aeration (see Materials and
methods) to simulate growth under a coverslip. The viabil-
ity of arp3-2 cells at 37°C, determined by methylene blue
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Figure 2
Growth and viability (plating efficiency) of
wild-type (RLY182) and arp3-2 mutant
(RLY193) strains at 23°C and 37°C. (a)
Growth curves were determined by growing
both strains at 23°C and 37°C in YPD and
measuring OD600 at 1 h intervals. (b) The
plating efficiency of arp3-2 mutant or wild-
type cells at 37°C was used as a measure of
viability and was determined by plating
dilutions of each culture on YPD plates at 0,
1, 2, 4 and 6 h after the temperature shift, and
counting colonies after 2–3 days of growth at
room temperature. Viability was determined
relative to the colony count at 0 h. 6420
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staining, remained constant during the entire 40 minute
time span of the patch-motility experiment (Figure 3c),
and dropped to 58% of that at t=0 after 4 hours (data not
shown). Furthermore, cells that were stained with methyl-
ene blue (i.e. dead cells) were not fluorescent and there-
fore are not likely to express GFP–Sac6 (data not shown).
To investigate whether metabolism in arp3-2 cells was
affected at the restrictive temperature, the rate of protein
synthesis was determined by pulse-labeling with 35S-
methionine. As shown in Figure 3c, the rate of 35S-methio-
nine incorporation decreased only slightly (to 84% of that
at t=0) after 1 hour at 37°C. These results indicate that the
effect of the arp3-2 mutation on actin-patch motility at the
restrictive temperature is not likely to be due to a general
sickness of these cells.
Arp3 function is required for cortical actin organization
As patch motility stops, some arp3-2 cells accumulate
large aggregates and cables that are not motile (Figure
3d); these structures were not counted as patches. Stain-
ing with phalloidin revealed that a longer inactivation of
Arp3 caused severe defects in actin organization. After a
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ARP3 inactivation impairs actin-patch motility. The actin distribution in
vivo visualized by GFP–Sac6 fluorescence in wild-type (RLY219) and
arp3-2 mutant (RLY218) strains after a 30 min incubation at 37°C is
shown in (a). Exposures were taken at 30 sec intervals. (b) The
percentage of moving patches was determined for wild-type and arp3-
2 mutant cells at room temperature (t = 0) and at 10 min intervals after
shifting to 37°C. For the arp3-2 mutant time course, 26, 51, 33, 68
and 28 cells were analyzed for the 0, 10, 20, 30 and 40 min time
points, respectively. For the wild-type time course, 18, 22, 34, 37 and
12 cells were analyzed for the 0, 10, 20, 30 and 40 min time points,
respectively. The percentages shown were averages of the results
from two experiments, and the error bars represent the standard
deviation. (c) Viability and rate of protein synthesis of arp3-2 cells
(RLY218) after incubation at 37°C for 1 h under simulated imaging
conditions. The percentage viability at each time point was determined
by methylene blue staining, as described in Materials and methods.
The percentages were normalized to percentage viable cells at room
temperature (t = 0) to give relative viability. The rate of protein
synthesis was determined by 35S-methionine incorporation as
described in Materials and methods. The count at each time point was
normalized to that at room temperature (t = 0) to give the relative rate
of protein synthesis. (d) Examples of aberrant GFP–Sac6 containing
structures in arp3-2 mutant cells after a 30 min incubation at 37°C.
The bar represents 10 mm.
Figure 4
Actin cytoskeleton defects caused by the
arp3-2 mutation. The images show rhodamine
phalloidin staining of RLY1 (wild-type) and
RLY193 (arp3-2 mutant) cells after a 1 h
incubation at 37°C: (a) budding and dividing
(abscessed) wild-type cells; (b) budding and
dividing (abscessed) arp3-2 cells with
aberrant cable-like actin structures in the bud
or at the septum, receptively. A large
multinucleate unbudded cell with actin
aggregated to one end in shown in (c). The
lower panel in (c) shows superimposed 4′, 6
diamino-2-phenylindole and phase images of
the same cell shown in the upper panel. The
bar represents 10 mm.
1 hour incubation at 37°C, actin patches in most (∼80%)
of the budded cells were replaced with bundle-like struc-
tures (Figure 4) that were similar in appearance to those
previously observed in cells lacking the expression of
Bee1, a yeast protein that is homologous to the Wiskott-
Aldrich syndrome protein (WASP) [17]. It was difficult to
determine whether actin cables were also affected
because the staining of actin cables was usually much
fainter than that of actin patches. Interestingly, in most of
the budded cells and even in a large fraction of the
unbudded cells (Figure 4c), the distribution of actin fila-
ments remained polarized. These observations suggest
that Arp3 is required for the assembly and organization of
cortical actin filaments, but not for maintaining the polar-
ity of actin distribution. 
Purification of the yeast Arp2/3 complex
To determine whether Arp3 exists in a protein complex,
the high-speed supernatant from cells expressing Myc-
tagged Arp3 (Arp3-M) was fractionated on a 5–20% sucrose
gradient. More than 80% of the soluble Arp3-M fraction-
ated as an 11S complex (Figure 5a). To identify biochemi-
cally the proteins that associate with Arp3, we introduced
tags that contained five Myc epitopes followed by six histi-
dine residues (Arp3-MH) to the carboxyl terminus of Arp3.
These tags do not affect Arp3 function in vivo (data not
shown). We developed a procedure to purify this complex
from Arp3-MH-expressing cells (see Materials and
methods): the soluble extract was first fractionated by two
ion-exchange columns, followed by fractionation through a
nickel column which binds to the histidine tag, and then
further purification by gel filtration. The Arp3-MH-con-
taining fractions were detected by immunoblotting using
an anti-Myc antibody. Arp3-MH always fractionates as a
single peak during each step. After the gel-filtration
column, six prominent bands of roughly equal stoichiome-
try were revealed by Coomassie-blue staining of the frac-
tion containing Arp3-MH (Figure 5b); these proteins
continued to co-fractionate over a mono-S column. 
Immunoblot analysis showed that the largest of the
proteins in the Arp3-MH-containing fraction, migrating at
about 70 kDa, is Arp3-MH. The other five proteins have
molecular weights of 43 kDa, 35 kDa, 19 kDa, 18 kDa and
15 kDa, similar to the apparent molecular weights of five
of the subunits of the Acanthamoeba and human Arp2/3
complexes. The Acanthamoeba [3] and human [5] com-
plexes contain proteins of 47 kDa, 44 kDa, 40 kDa,
35 kDa, 19 kDa, 18 kDa, 13 kDa and 50 kDa, 43 kDa,
40/39 kDa 34 kDa, 23 kDa, 22 kDa, 19 kDa, respectively.
The yeast Arp3-containing complex therefore does not
contain a 40 kDa subunit like that found in both the
Acanthamoeba and human Arp2/3 complexes. The Stokes
radius of the yeast complex, determined by gel filtration,
is 5.3 nm, similar to that of the Acanthamoeba (5.3 nm) and
human (5.5 nm) Arp2/3 complexes [5,6].
Identification of the subunits of the Arp2/3 complex by
mass spectrometry
As the molecular weights of the non-actin-related Arp2/3
complex subunits are similar between the species, these
proteins are likely to carry out a conserved and important
function; however, the sequences of these subunits have
not yet been reported. We used a high accuracy mass-
mapping technique to identify the amino-acid sequences
of all yeast Arp2/3 complex subunits. The six Coomassie-
blue-stained protein bands corresponding to the members
of the complex were processed [18] and analyzed by
matrix-assisted laser desorption ionization (MALDI).
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Figure 5
Purification of yeast Arp2/3 complex. (a) Lysate from RLY187 (Myc-
tagged-Arp3-expressing) cells was fractionated on a 5–20% sucrose
gradient as described in Materials and methods. The position at which
catalase (232 kDa) eluted when run in parallel on an identical gradient is
indicated. Fractions (0.75 ml) were obtained from the gradient and
immunoblot analysis was performed on alternate fractions to determine
the presence of Arp3 and actin. Load, the extract loaded on the gradient.
(b) A Coomassie-blue-stained 12.5% polyacrylamide gel showing the
protein profile of the peak Arp3-MH-containing fractions after each
purification step (from left to right). Marker, 10 kDa ladder protein
molecular weight markers (Life Technologies); Extract, the starting
extract; Q-ft, Q Sepharose column flow-through; S-eluate, S-Sepharose
eluate; Ni-eluate, eluate from the nickel column; GF, peak from S-300 gel
filtration column; S2-eluate, eluate from UNO S1 column.
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Peptide-mass maps of high resolution and mass accuracy
were obtained for all bands. Figure 6 shows the result of
one of the peptide-mapping experiments; a mass accuracy
better than 50 ppm was obtained. A search of the
database (see Materials and methods) identified a previ-
ously uncharacterized open reading frame in the yeast
genome with calculated molecular weight of 20.8 kDa, in
agreement with the observed molecular weight of
18 kDa. A match within 50 ppm of the mass of a pre-
dicted tryptic peptide was found for 13 peptides, covering
68% of the sequence. Analysis of the other bands identi-
fied the 45 kDa protein as Arp2 (data not shown) and the
uncharacterized open reading frames corresponded to the
other subunits (Figure 7a).
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Figure 6
Peptide map of the band corresponding to
Arc18 in Figure 5. The figure shows a high
mass-accuracy peptide-mass map of the
unseparated tryptic peptide mixture derived
from the protein in the second lowest
molecular weight band in the S2-eluate lane in
Figure 5b. The measured mass and the
deviation from the calculated mass is
indicated for the 13 peptides that fit within
50 ppm with the calculated masses of tryptic
peptides of the protein found by a database
search. Closed circles indicate trypsin
autolysis products.
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Figure 7
a) Amino-acid sequences of Arc15 (EMBL/
Genebank accession number: Z38060, ORF
name: YNR035c), Arc18 (Swiss Protein
database accession number: P33204, ORF
name: YKL013c), Arc19 (EMBL/ Genebank
accession number: U19103, ORF name:
L8039.15) and Arc35 (EMBL/ Genebank
accession number: Z71650, ORF name:
YIL062c). Sequence alignment of Arc15 with
a homologous S. pombe protein (Swiss
Protein database accession number: P33204)
(b), and the peptides in Arc18 (c), Arc19 (d)
and Arc35 (e) with the related peptides in the
Acanthamoeba (Ac.) P18, P19 and P35
subunits, respectively [3]. Conserved residues
and those with conserved substitutions are
shaded.
Arc1
MLHLQPQNLLIQKTLNEAIEALRKGSPLTMDRIVSDFDYT 40

TYHISNTAEDKSILLLSVKTKAWVSVSECQLDGSLTLLKF 80

LADHYSSLGGVTIPSEVEPGYDYTLQITLAELVQESILQL 120

SVLKTIILSFPFELAISKFIELSQQQPAPVEAEITGGEVA 160
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MEADWRRIDIDAFDPESGRLTAADLVPPYE 30
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GLKTLLSYVPYGNDVQEVRTQYLNAFVDVLSNIRAADIPAFVKECSTEEIDNIVNFIYRG55
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NKHTESMKTGKLVDFIIEFMEDVDKEISEI 150
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Genes corresponding to the 15 kDa, 18 kDa, 19 kDa and
35 kDa subunits were named ARC15, ARC18, ARC19 and
ARC35, respectively (ARC is an abbreviation for Arp2/3
complex). Short peptide sequences have been published
for the 18 kDa, 19 kDa, and 35 kDa subunits of the Acan-
thamoeba Arp2/3 complex, and these sequences are homol-
ogous to regions of Arc18, Arc19 and Arc35, respectively
(Figure 7c–e). The peptide sequence for the Acanthamoeba
13 kDa subunit, which probably corresponds to Arc15, has
not been published. Database searches identified an
Schizosaccharomyces pombe homologue of Arc15 (Figure 7b).
Searches of the expressed sequence tag (EST) database
identified possible human homologues of all of the Arcs,
and mouse homologues of Arc15, 19 and 35 (data not
shown), indicating that the primary structures of all Arp2/3
complex subunits are probably conserved between species.
Discussion
Arp2/3 complex is highly conserved in eukaryotic cells
We have purified the yeast Arp2/3 complex and identified
the complete amino-acid sequences of its subunits. Molec-
ular weight and sequence comparisons between the yeast
Arp2/3 complex subunits and the corresponding subunits
from other species indicated that the Arp2/3 complex is
probably conserved throughout eukaryotic organisms. This
finding provides an opportunity for studying the function
of the Arp2/3 complex by genetic approaches in yeast.
A noteworthy difference between the Acanthamoeba and
yeast Arp2/3 complexes is the absence of a 40 kDa polypep-
tide in yeast. By searching the genome database with the
short peptide sequences published by Machesky et al. [3],
we have identified a putative S. cerevisiae homologue of this
subunit which is also homologous to the recently published
Sop2 protein from S. pombe [19]. In S. pombe cells, Sop2
protein does not localize to actin patches as Arp3 does, sug-
gesting that Sop2 may not always be associated with Arp3.
In some preparations of the human complex, p40 appears to
be a sub-stoichiometric component [5]. Therefore, p40 may
loosely associate with Arp2/3 complex, or more interest-
ingly, the association may be regulated. The  S. cerevisiae
Sop2 homologue is essential for cell viability (D. Winter
and R. Li, unpublished observations), indicating that its
function in vivo is not dispensable.
The function of Arp2/3 complex in vivo
The association of the Arp2/3 complex with dynamic struc-
tures, such as the pseudopods of Acanthamoeba or the actin
tails of rapidly moving Listeria cells, suggested that this
complex had a role in motility driven by actin
polymerization [3–6]. The fact that both Arp2 [20] and Arp3
(this study) localize to the highly motile actin patches raises
the possibility that the Arp2/3 complex may play a similar
role in yeast. We used a conditional arp3 allele to test the
hypothesis that the Arp2/3 complex may be involved in
actin-patch motility. At the permissive temperature, we
observed no difference in actin patch movement between
wild-type and arp3-2 cells. After shifting to the restrictive
temperature for 30 minutes, a dramatic reduction in actin-
patch movement was apparent in the mutant cells. 
The arp3-2 mutation is the first mutation identified that
impairs actin-patch motility. This effect is not likely to be
due to a general defect in cortical actin organization,
because several mutations that affect cortical actin organi-
zation, including Dtpm1, Dtpm2 [13], Dsac6, Dsla2 and
Daip1 (Tim Doyle, personal communication), do not
inhibit actin-patch motility. A direct role for Arp3 in
actin-patch movement is consistent with the observations
that Arp3 localizes to actin patches and that arp3-2 has a
rapid effect on patch motility prior to any significant
reduction in either cell viability or the rate of protein syn-
thesis. This role in motility is likely to be fulfilled by the
Arp2/3 complex, because most Arp3 is found associated
with the complex.
Arp3 inactivation eventually leads to disruption of cortical
actin patches. This defect appears to occur after the cessa-
tion of patch movement. The precise relationship
between the defect in patch integrity and that in patch
motility is not clear. The aberrant cable-like structures
that accumulate in arp3-2 cells at the restrictive tempera-
ture are similar in appearance to those structures seen in
cells lacking Bee1 [17], suggesting that Arp3 and Bee1
may be involved in the same process. We have recently
demonstrated that Bee1 stimulates actin polymerization at
cortical patches in a reconstituted system [21]. Interest-
ingly, the amino-terminal half of Bee1 exhibits structural
similarity with VASP, a protein that controls actin poly-
merization during Listeria movement (for reviews, see
[22,23]). Although the primary sequence homology is
limited, both proteins contain an amino-terminal WASP
homology domain I [24], followed by the G/APPPPP pro-
filin-binding motifs [25,26]: perhaps the functional rela-
tionship between Arp2/3 complex and Bee1 in yeast is
similar to that between Arp2/3 complex and VASP in the
Listeria system.
A model for actin-patch motility in yeast
There are two known types of actin-based motility: one is
driven by myosin along actin filaments, and the other is
driven by actin polymerization, as utilized by Listeria. It
seems unlikely that yeast actin patches move by a motor-
driven mechanism, because the patches do not move
along apparent tracks, such as actin cables or
microtubules, but move independently of one another,
even when localized to the same cellular regions. This
observation is consistent with the finding that actin-patch
motility is not affected by mutations in any of the known
class I or class V myosins in yeast [13]. The dependence of
patch motility on the Arp2/3 complex suggests that this
motility may be similar to that of Listeria.
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A polymerization-driven mechanism for actin-patch
motility could bypass the requirement for motors and
explain the lack of apparent tracks. The rate of actin-patch
movement (0.1–0.6 mm/sec) [13] is comparable to that of
Listeria movement (0.14–1.46 mm/sec) [27], suggesting
that a polymerization-driven mechanism is possible. VASP
binds to ActA, a Listeria surface protein and forms a
complex with profilin, an actin-monomer-binding protein
(for reviews, see [22,23]). This VASP–profilin complex
might locally stimulate the polymerization of actin fila-
ments, which itself might be nucleated or recruited by the
Arp2/3 complex [5,23]. The conservation of Arp2/3 com-
plexes, the similarity between Bee1 and VASP, and the
presence of profilin in yeast [28] suggest that a similar
mechanism may control actin polymerization during actin-
patch movement.
A new tool for rapid identification of proteins in yeast
Mass spectrometric methods are now able to conclusively
and rapidly link gel-separated proteins with their cognate
genes in the database [29]. This analytical method is partic-
ularly useful for the rapid identification of yeast proteins, as
the sequencing of the genome has recently been completed
[30]. Here we demonstrate that MALDI peptide-mapping
with high mass-accuracy, a method that does not involve
any peptide sequencing, is valuable for identifying com-
plete multiprotein complexes. Tryptic peptides are mea-
sured by mass and the list of measured masses is screened
against the list of calculated peptide masses for each protein
or open reading frame in a sequence database. The
improvement in search specificity necessary for unambigu-
ous identification by this method was made possible by
recent advances in sample preparation, mass spectrometric
instrumentation and software algorithms [18,31]. Combined
with genetic methods, these mass spectrometric tools
should be particularly powerful in yeast, as we have shown
here in our studies of the Arp2/3 complex.
Materials and methods
Plasmids, strains and genetic manipulations
The yeast strains and plasmids that were used are listed in Tables 1
and 2. Yeast cell culture and genetic techniques were carried out by
methods described by Sherman et al. [32]. All plasmid construction
was performed using standard techniques.
Gene disruption of ARP3
An ARP3 disruption plasmid (pDW4) was constructed in which 94% of
the coding region (amino acids 1–420) and 32 bp sequence 5′ to the
open reading frame in the ARP3 gene was replaced by the HIS3 marker
gene. To generate the Darp3 strain, pDW4 was cut with SacII and SalI
and transformed into a His– diploid yeast strain. The diploid was sporu-
lated and the tetrads were dissected and analyzed: 18 tetrads showed
2:2 lethality, and no viable His+ spores were recovered. The correct inte-
gration of the disruption construct was confirmed by Southern hybridiza-
tion analysis (data not shown). The lethality of His+ spores was rescued
by pDW8 and pDW15 plasmids expressing the wild-type ARP3. 
Immunofluorescence
Cells were fixed directly in growth media by addition of 37% formalde-
hyde to 5% final concentration. Immunofluorescence staining was
carried out essentially as described [15]. Rhodamine-conjugated
donkey anti-goat and FITC-conjugated donkey anti-mouse secondary
antibodies were purchased from Jackson Immunoresearch.
Generating conditional arp3 alleles
Mutagenic PCR conditions of Caldwell and Joyce [33] were used to
amplify a 1.76 kb DNA fragment containing the entire ARP3 coding
region and 250 bp and 143 bp upstream and downstream sequences
respectively. A 100 ml reaction contained 100 ng pDW3 template
DNA, 125 pmol primers 5′-CGCGCGTCTAGACCTGCTAGCCG-
GTTGATGTA-3′ and 5′-CGCGCGAAGCTTCAGCATTTGGGGT-
TACTTGA-3′, 1.5 mM MgCl2, 0.2 mM MnCl2, 1 mM dATP and dGTP,
0.2 mM dCTP and dTTP, 5 U Taq and 1 × Boehringer Taq buffer
(Boehringer Mannheim). The PCR product was co-transformed with
StuI and BglII digested pDW15 plasmid into RLY180, and transfor-
mants were selected on leucine deficient synthetic media. To select
against the pDW8 plasmid containing wild-type ARP3, 647 transfor-
mants were patched onto 5-fluoroorotic acid (5-FOA) plates: 507
colonies were able to grow on 5-FOA media. These colonies were
replica-plated onto YPD plates and allowed to grow at room tempera-
ture, 14°C and 37°C: nine temperature-sensitive and no cold-sensitive
colonies were isolated. Plasmids were rescued and transformed into
RLY1 and RLY180 to test dominance and re-examine thermosensitivity.
Ultimately, eight recessive temperature-sensitive alleles were isolated.
Determination of viability using methylene blue
Methylene blue staining was performed essentially as described in
[34]. RLY218 cells, grown to early log phase in SD media lacking
uracil and tryptophan, were concentrated to 107–108 cells per ml.
Cells were covered in mineral oil to prevent aeration and gently shaken
in a 37°C water bath to prevent pellet formation. At each time point, an
aliquot of the cells was diluted with an equal volume of 0.01% methyl-
ene blue/2% sodium citrate solution. The number of cells that were
negative and positive for methylene blue staining were determined
microscopically within 10 min of mixing. A minimum of 200 cells were
scored per time point.
Measurement of protein synthesis
The rate of protein synthesis was measured as described in [35].
RLY218 cells, grown to early log phase in SD media lacking uracil and
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Table 1
Yeast strains used in this study
Name Genotype Source
RLY1 MATa ura3-52, his3-∆200, leu2-3, lys2-801 Drubin lab
RLY180 MATa/Matα ura3-52/ura3-52, his3-∆200/ This work
his3-200, leu2-3/leu2-3, lys2-801/lys2-801,
∆arp3::HIS3/ARP3
RLY182 MATa ura3-52, his3-200, leu2-3, lys2-801 This work
∆arp3::HIS3, pDW15
RLY187 MATa ura3-52, his3-∆200, leu2-3, lys2-801 This work
∆arp3::HIS3, pDW19
RLY188 MATa ura3-52, his3-∆200, leu2-3, lys2-801 This work
∆arp3::HIS3, pDW20
RLY193 MATa ura3-52, his3-∆200, leu2-3, lys2-801 This work
∆arp3::HIS3, pDW25
RLY218 MATa ura3-52, his3-∆200, leu2-3, lys2-801 This work
∆arp3::HIS3, pDW25, pRB2140
RLY219 MATa ura3-52, his3-∆200, leu2-3, lys2-801, This work
pRB2140
All of the above strains are congenic in a S288C background.
tryptophan, were concentrated to an 107–108 cells per ml. Cells were
covered in mineral oil to prevent aeration and gently shaken in a 37°C
water bath to prevent pellet formation. At each time point, 200 ml cells
were removed, incubated with 1 mCi of 35S methionine for 5 min, and
spotted onto 3MM Whatman paper presoaked in 50% TCA. The
strips of paper were boiled and washed in 10% TCA and 35S-incorpo-
ration was determined by liquid scintillation counting. 35S-incorpora-
tion in sodium-azide-treated cells or arp3-2 cells grown overnight at
37°C was less than 2% of that incorporated by the untreated cells
(data not shown).
Imaging of actin-patch movement
Exponential cultures of RLY218 and RLY219 were grown at room
temperature in SD media lacking uracil and resuspended in SD
media lacking tryptophan and uracil prior to microscopy. Cells were
concentrated to 107–108 per ml in the same media. For each experi-
ment, a series of slides were prepared at room temperature by spot-
ting 5 ml cells on a microscope slides, covering them with a coverslip,
and sealing the coverslip with Valap wax (a 1:1:1 mix of paraffin,
vaseline and wax). Slides were then incubated at 37°C for various
amounts of time. At 10 min intervals, slides were removed from the
37°C incubation. Imaging was performed using a Zeiss Plan-APOC-
HROME 63X/1.40 objective on a Zeiss Axioskop microscope
equipped with a CH250/KAF-1400 liquid-cooled charge-coupled
device camera (Photometrics). Image processing was performed on
Metamorph 2.5 (Universal Imaging Corp.). All movies were made
within 6 min of removing slides from 37°C to minimize recovery.
Patch movement was quantified by determining the percentage of
patches present in the first frame of the movie that moved 1 mm or
more within the plane of focus or disappeared out of focus during the
span of the movie. Aberrant structures that appeared in mutant cells
at 37°C were not counted as patches.
Phalloidin staining of yeast cells
Cells were fixed directly in growth media by addition of 37% formalde-
hyde to 5% final concentration. Staining with rhodamine-labeled phal-
loidin (Molecular Probes) was carried out as described in [36].
Arp2/3 complex purification
RLY188 cells were grown to late log phase in 9 L YPD media. Cells
were washed once in and resuspended in 200 ml of 4°C U buffer
(50 mM Hepes, pH 7.5, 100 mM KCl, 3 mM MgCl2, 1 mM EGTA) sup-
plemented with 0.2 mM ATP and 1 × protease inhibitor mix (PI;
0.5 mg/ml of each of antipain, leupeptin, pepstatin A, chymostatin, apro-
tinin and 1 mM PMSF). This cell suspension was passed once through a
French pressure cell press (Aminco) at 1200 psi. Membranes and cell
debris were cleared by centrifugation at 40,000 r.p.m. in a Beckmann
TI45 rotor for 2 h. The supernatant was further cleared of aggregates by
passage through a 0.8 mm filter (Corning Glass Works).
All of the column chromatography experiments were performed at 4°C
on the BioLogic automated protein purification system (Bio-Rad),
except for the Ni2+ column, which was run manually. A 260 ml extract
(10 mg/ml) was applied to a 80 ml Q Sepharose column (Macro-Prep
Q, Bio-Rad), equilibrated with U buffer + ATP + PI. This column was
washed with three column volumes of U buffer + ATP + PI, and eluted
with a 640 ml salt gradient (0.1–0.55 M KCl in U buffer + ATP + PI).
Immunoblot analysis revealed that all Arp3 protein elutes between 170
and 240 mM KCl. The Arp3-containing fractions were pooled, diluted
to 50 mM KCl in H2O, adjusted to pH 6.5 with 0.5 M MES (2-[N-mor-
pholino] ethanesulfonic acid), pH 3.2, and applied to a 20 ml S
Sepharose column (Bio-Rad), equilibrated in 25 mM MES, pH 6.5,
25 mM KCl, 0.5 mM MgCl2, supplemented with PI and ATP. This
column was washed with four column volumes of the same buffer and
eluted with a 100 ml gradient of 25–320 mM KCl. All detectable Arp3
eluted between 160 and 300 mM KCl. Peak fractions were pooled,
adjusted to pH 7.5 with Tris-HCl, pH 9.1, and passed over a 1 ml Ni-
NTA agarose column (Qiagen), equilibrated in U buffer + ATP + PI.
This column was washed with 20 ml of 0.3 M KCl U buffer + ATP + PI,
then 15 ml of 0.1 M KCl, and eluted in batch with 50 mM imidazole.
The Arp3-containing eluate was passed over a 1 × 120 cm gel filtration
column of Sephacryl S-300 (Pharmacia). Coomassie-blue-staining indi-
cated that Arp3 fractionated as a single peak of six bands of roughly
equal stoichiometry. The peak fractions were diluted to 50 mM KCl,
adjusted to pH 6.5 with MES, and passed over a UNO-S1 column
Research Paper  Yeast Arp2/3 complex Winter et al. 527
Table 2
Plasmids used in this study
Plasmid Description
pDW2 A 1.76 kb XbaI—HindIII fragment containing the complete ARP3 coding region and 250 bp upstream and 143 bp downstream 
sequences was amplified by PCR from genomic DNA using primers 5′-CGCGCGTCTAGACCTGCTAGCCGGTTGATGTA-3′
and 5′-CGCGCGAAGCTTCAGCATTTGGGGTTACTTG-3′ and cloned into the XbaI and HindIII sites of pSK+ (this study).
pDW4 The StuI–EcoRI fragment of ARP3 containing 94% of the ARP3 open reading frame was deleted from pDW2 and replaced 
with the YDp-H [42] HIS3 fragment (this study).
pDW8 The XbaI and HindIII ARP3 fragment from pDW2 was cloned into pRS316 [41] (this study).
pDW15 The XbaI and HindIII ARP3 fragment from pDW2 was cloned into pRS315 [41] (this study).
pDW16 In order to generate an in-frame BamHI site at the 3’ end of ARP3, a 1.59 kb XbaI–BamHI fragment of ARP3 was amplified by 
PCR from pDW2 using primers 5′-CGCGCGTCTAGACCTGCTAGCCGGTTGATGTA-3′ and 5′-GCGCGGGATCCAACCATG-
TTGAAAAGGCTG-3′ and cloned into the XbaI and BamHI sites of pSK+ (this study).
pDW19 The XbaI and BamHI ARP3 fragment from pDW2 was cloned into pRL72 (this study).
pDW20 The XbaI and BamHI ARP3 fragment from pDW2 was cloned into pRL122 (this study).
pDW25 arp3-2 in pRS315 [41] as generated in Materials and methods (this study).
pRB2140 GFP–SAC6 expressed under the ACTI promoter in a URA, CEN, ARS plasmid [12].
pRL172 A pRS315-based [41] vector containing the same cassette as in pRL102 [17] for carboxy-terminal tagging with six Myc epitopes 
(this study).
pRL122 A pRS316-based [41] vector for carboxy-terminal tagging with five Myc epitopes followed by six histidines (this study).
(Bio-Rad). A 10 ml gradient of 25–320 mM KCl eluted these bands in
a single 2 ml fraction at 170 mM KCl.
Stokes radius determination
The method of Siegel and Monty [37] was used to determine Stokes
radius of purified Arp2/3 complex. A 1 × 120 cm HiPrep Sephacryl S-
300 column (Pharmacia Biotech) was equilibrated with U buffer. ATP
marked the salt volume and blue dextran (Mr = 2,000 kDa) marked the
void volume. Catalase (Mr = 232 kDa) and ferretin (Mr = 440 kDa) from
Pharmacia were used as standards.
Sucrose gradient
A RLY187 lysate was prepared in U buffer + ATP + PI by the liquid
nitrogen grinding method [38], and cleared by a 1 h centrifugation at
80,000 r.p.m. in RP100-AT3 rotor (Du Pont) . A 12 ml 5–20% sucrose
gradient was prepared in the same buffer, and 200 ml lysate was
loaded. After a 15 h centrifugation in an SW40 rotor (Beckman Instru-
ments) at 35,000 r.p.m. at 4°C, 0.75 ml fractions were collected, pre-
cipitated with TCA and subjected to immunoblot analysis. Ferritin and
catalase were run in parallel on an identical gradient as standards.
Immunoblot analysis
Immunoblotting analysis with anti-Myc and anti-actin antibodies was
carried out as described in [17].
Protein identification by mass spectrometry
Bands of interest were excised from the gel, washed, in-gel reduced,
S-alkylated and subjected to proteolytic digestion with an excess of
sequence grade trypsin (Boehringer Mannheim) as described [29,39].
A mixture of saturated solution of a-cyano-hydroxycynnamic acid
(Sigma) and nitrocellulose in acetone (Bio-Rad) were used to prepare
‘fast evaporation’ matrices for MALDI analysis [29,31,40]. After a 3 h
digestion, 0.3 ml digestion supernatant was removed and deposited
directly into an acidified water droplet placed on top of these matrix
surfaces. Peptide-mass maps were recorded on a Bruker time-of-flight
mass spectrometer equipped with a delay ion-extraction source, nitro-
gen 337 nm laser and Scout device for multiprobe operation (Bruker-
Franzen). Data were acquired using a Lecroy 9350AM (1
Gsamples/sec) digital storage oscilloscope and were analyzed on a
Macintosh Power PC 7100/80 (Apple) using the LaserOne software
package (P. Mortensen and M. Mann). The spectra were obtained as
averages of 40–100 single laser shots.
Resolution was sufficient to assign monoisotopic masses to all peptide
peaks and these masses were searched against a comprehensive
sequence database (http://www.mann.embl heidelberg.de/Services/
PeptideSearch/PeptideSearchIntro.html). Tryptic autolysis peaks and
matrix-related peaks were used for internal calibration. 
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